Purchase Order 75N91023P00667

Award Date 7/31/23
Potential Completion Date 8/31/23
Potential Value $13K
Ultimate Awardee
Bio-Techne Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,696 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. of Newark, California for lab testing services. As the prime contractor, Advanced Cell Diagnostics will provide the requested testing services to the agency. Advanced Cell Diagnostics is a subsidiary of Bio-Techne Corporation, located in Newark. The award does not have a set-aside designation. The contract has a...
Advanced Cell Diagnostics, Inc., doing business as ACD, has been awarded a firm fixed price purchase order valued at $10,574.80 by the National Institutes of Health's National Institute of Mental Health to provide reagents including the RNAScope Hiplex Probe, RNAScope Intro Pack for Hiplex 12 reagents kit. Performance will take place in Newark, California from July 5, 2023 through September 30, 2023. The award is for reagents to support the NIH's biomedical research efforts. No set aside...
This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $10,488.08 contract is for the provision of ACD's proprietary RNAscope technology and related products, which enable the visualization and quantification of RNA biomarkers. This contract supports biomedical research efforts across various National Institutes of...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $18,690.00 contract provides ACD's proprietary RNAscope assay biological products, including kits, reagents, and probes, to support various biomedical research efforts across NIH. These products enable the visualization and...
This contract award is to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation, by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH). The $5,110.00 firm-fixed-price purchase order is for ACD's proprietary RNAscope technology and related products to support biomedical research efforts across various NIH institutes and other federal agencies. ACD's expertise in RNA detection has made it a valuable...
This firm-fixed-price purchase order was awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Advanced Cell Diagnostics, Inc. (ACD) on September 18, 2020. The $19,999.60 award has an ultimate completion date of September 30, 2021 and does not have a set-aside designation. ACD, a subsidiary of Bio-Techne Corporation, is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. The company has...
This federal contract award, valued at $10,912.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract is for the provision of reagents and kits, with no set-aside designation. ACD is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. Through this firm-fixed-price purchase order, ACD will...
This federal contract awards $34,976.00 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics, to provide the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases with various RNAscope kits and reagents. The contract is a firm-fixed-price purchase order with no set-aside designation. ACD, a subsidiary of Bio-Techne Corporation, has a strong track record of providing these types of...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $3,857.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a division of Bio-Techne Corporation, doing business as Bio-Techne. The contract is for the delivery of RNAscope probes, reagent kits, and related products to support research efforts being conducted at the agency's Bethesda, Maryland campus. As the leading...
This $4,960 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company that specializes in RNA detection technologies. The contract is for the provision of reagent kits, which ACD supplies to support biomedical research efforts across various National Institutes of Health (NIH) institutes and other federal agencies. ACD's proprietary RNAscope technology and related...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,128 purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, for reagents. ACD is a division of Bio-Techne Corporation, doing business as Bio-Techne. The firm fixed price order runs from July 31, 2023 through August 31, 2023 for delivery to ACD's Newark, California facility. No additional details were provided on the original solicitation, major subcontractors, or set aside designations. The National Cancer Institute supports cancer research through intramural and extramural programs aimed at understanding cancer causes and mechanisms, advancing cancer prevention, diagnosis, and treatment.

Generated 12/24/23, 2:29 AM